West Pharmaceutical Services WST Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $138.8M+5.1% | $132.1M-5.6% | $140M+6.2% | $131.8M+46.8% | $89.8M-31.0% | ||
| $44.6M-3.9% | $46.4M+9.7% | $42.3M+3.7% | $40.8M+4.3% | $39.1M-1.8% | ||
| $6.6M-1.5% | $6.7M-20.2% | $8.4M+13.5% | $7.4M+469% | $1.3M-69.8% | ||
| $300K-95.9% | $7.3M+2,333% | $300K-92.1% | $3.8M+1,167% | $300K-94.4% | ||
| —— | -$1.73M0.0% | -$1.73M0.0% | -$1.73M0.0% | -$1.73M-112% | ||
| —— | $15.7M0.0% | $15.7M0.0% | $15.7M0.0% | $15.7M+250% | ||
| —— | $4.48M0.0% | $4.48M0.0% | $4.48M0.0% | $4.48M+517% | ||
| -$1M+99.1% | -$112.5M-4,400% | -$2.5M-163% | $4M+37.9% | $2.9M+109% | ||
| —— | -$2.43M0.0% | -$2.43M0.0% | -$2.43M0.0% | -$2.43M-267% | ||
| —— | $2.63M0.0% | $2.63M0.0% | $2.63M0.0% | $2.63M-21.6% | ||
| $89.9M-64.2% | $251.1M+27.3% | $197.2M+11.3% | $177.1M+36.9% | $129.4M-31.9% | ||
| $42.7M-43.9% | $76.1M+20.2% | $63.3M-15.8% | $75.2M+5.5% | $71.3M-32.0% | ||
| -$42.7M+43.9% | -$76.1M-20.2% | -$63.3M+15.8% | -$75.2M-5.5% | -$71.3M+32.0% | ||
| $15.8M0.0% | $15.8M+4.6% | $15.1M0.0% | $15.1M-0.7% | $15.2M-0.7% | ||
| $297.6M— | —— | —— | $500K-99.6% | $133.5M+145% | ||
| $5.5M+77.4% | $3.1M+40.9% | $2.2M-37.1% | $3.5M+40.0% | $2.5M+66.7% | ||
| $300K0.0% | $300K0.0% | $300K0.0% | $300K+50.0% | $200K+100% | ||
| $2.5M+1,150% | $200K+100% | $100K— | $0-100% | $2.5M+1,150% | ||
| -$308.7M-2,538% | -$11.7M-1.7% | -$11.5M+22.8% | -$14.9M+89.9% | -$147M-113% | ||
| -$8.4M— | —— | —— | $18.5M+118% | $8.5M+137% | ||
| -$269.9M-266% | $162.8M+37.0% | $118.8M+12.6% | $105.5M+231% | -$80.4M-1,176% | ||
| —— | $75K0.0% | $75K0.0% | $75K0.0% | $75K-40.0% | ||
| —— | $31.3M0.0% | $31.3M0.0% | $31.3M0.0% | $31.3M+75.4% | ||
| $600K0.0% | $600K-14.3% | $700K+16.7% | $600K-33.3% | $900K0.0% | ||
| $300K-95.9% | $7.3M+2,333% | $300K-92.1% | $3.8M+1,167% | $300K-94.4% | ||
| $44.6M-3.9% | $46.4M+9.7% | $42.3M+3.7% | $40.8M+4.3% | $39.1M-1.8% | ||
| —— | $2.63M0.0% | $2.63M0.0% | $2.63M0.0% | $2.63M-21.6% | ||
| $102.9M— | —— | —— | $4.1M+4,200% | -$100K— | ||
| —— | -$2.43M0.0% | -$2.43M0.0% | -$2.43M0.0% | -$2.43M-267% | ||
| -$1M-133% | $3M— | —— | $4M+37.9% | $2.9M— | ||
| —— | $150K0.0% | $150K0.0% | $150K0.0% | $150K+130% | ||
| $300K0.0% | $300K0.0% | $300K0.0% | $300K+50.0% | $200K+100% | ||
| $2M+33.3% | $1.5M-16.7% | $1.8M+5.9% | $1.7M-10.5% | $1.9M+18.8% | ||
| $900K— | —— | $900K+12.5% | $800K0.0% | $800K— | ||
| —— | $31.3M0.0% | $31.3M0.0% | $31.3M0.0% | $31.3M+75.4% | ||
| $47.2M-73.0% | $175M+30.7% | $133.9M+31.4% | $101.9M+75.4% | $58.1M-31.8% | ||
| $47.2M-73.0% | $175M+30.7% | $133.9M+31.4% | $101.9M+75.4% | $58.1M-31.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
